The exact cause of polymyalgia rheumatica (PMR) is unknown. Studies of patients with PMR and giant-cell arteritis indicate that PMR could be a vasculitis limited to the subclavian or axillary ...

Reports Insights analyzes that the polymyalgia rheumatica treatment market is growing with a CAGR of 4.2% during the forecast period (2023-2030), and the market is projected to be valued at USD ...

Three times more patients treated with Kevzara achieved sustained remission compared to placebo in Phase 3 trial Kevzara now approved to treat two chronic inflammatory disorders TARRYTOWN, N.Y ...

Sparrow Pharmaceuticals Presents Data from Ongoing Phase 2 Trial of Clofutriben (SPI-62) and Prednisolone as a Treatment for Polymyalgia Rheumatica at EULAR 2024 June 15, 2024 07:00 AM Eastern ...